Abstract
Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.
| Original language | English |
|---|---|
| Pages (from-to) | 60-66 |
| Number of pages | 7 |
| Journal | Journal of the Neurological Sciences |
| Volume | 348 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - Jan 15 2015 |
Fingerprint
Keywords
- Chronic migraine
- Detoxification
- Disability
- Health-related quality of life
- Medication overuse
- Withdrawal
ASJC Scopus subject areas
- Clinical Neurology
- Neurology
Cite this
Chronic migraine with medication overuse : Association between disability and quality of life measures, and impact of disease on patients' lives. / Raggi, Alberto; Schiavolin, Silvia; Leonardi, Matilde; Giovannetti, Ambra Mara; Bussone, Gennaro; Curone, Marcella; Di Fiore, Paola; Grazzi, Licia; Usai, Susanna; D'Amico, Domenico.
In: Journal of the Neurological Sciences, Vol. 348, No. 1-2, 15.01.2015, p. 60-66.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Chronic migraine with medication overuse
T2 - Association between disability and quality of life measures, and impact of disease on patients' lives
AU - Raggi, Alberto
AU - Schiavolin, Silvia
AU - Leonardi, Matilde
AU - Giovannetti, Ambra Mara
AU - Bussone, Gennaro
AU - Curone, Marcella
AU - Di Fiore, Paola
AU - Grazzi, Licia
AU - Usai, Susanna
AU - D'Amico, Domenico
PY - 2015/1/15
Y1 - 2015/1/15
N2 - Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.
AB - Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.
KW - Chronic migraine
KW - Detoxification
KW - Disability
KW - Health-related quality of life
KW - Medication overuse
KW - Withdrawal
UR - http://www.scopus.com/inward/record.url?scp=84920996909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920996909&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2014.11.004
DO - 10.1016/j.jns.2014.11.004
M3 - Article
C2 - 25434715
AN - SCOPUS:84920996909
VL - 348
SP - 60
EP - 66
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
SN - 0022-510X
IS - 1-2
ER -